tiprankstipranks
NVE Corporation (NVEC)
NASDAQ:NVEC

NVE (NVEC) AI Stock Analysis

Compare
211 Followers

Top Page

NVEC

NVE

(NASDAQ:NVEC)

Select Model
Select Model
Select Model
Outperform 81 (OpenAI - 5.2)
Rating:81Outperform
Price Target:
$77.00
▲(22.87% Upside)
Action:ReiteratedDate:01/23/26
The score is driven primarily by strong financial quality (high profitability, low leverage, solid cash conversion). The latest earnings call was supportive with strong quarterly performance and constructive operational developments, partially offset by margin compression and uneven year-to-date trends. Technicals are bullish but overextended, which tempers the overall score, while valuation is supported by a high dividend but only moderate on P/E.
Positive Factors
Very conservative balance sheet
Extremely low leverage and equity-heavy capital structure give the company durable financial flexibility. This supports investment in capacity, consistent dividend payouts, and resilience through semiconductor cycles while keeping bankruptcy and refinancing risk minimal.
Negative Factors
Uneven revenue and growth trends
Inconsistent top-line momentum reduces visibility for capacity utilization and R&D ROI. Post-peak normalization and lumpy revenue make planning and scaling harder, increasing the risk that investments won't translate into steady long-term growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Very conservative balance sheet
Extremely low leverage and equity-heavy capital structure give the company durable financial flexibility. This supports investment in capacity, consistent dividend payouts, and resilience through semiconductor cycles while keeping bankruptcy and refinancing risk minimal.
Read all positive factors

NVE (NVEC) vs. SPDR S&P 500 ETF (SPY)

NVE Business Overview & Revenue Model

Company Description
NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, incl...
How the Company Makes Money
NVE primarily makes money through two main revenue streams: (1) product sales and (2) intellectual property licensing/royalties. Product revenue is generated by selling spintronic-based devices—such as magnetoresistive sensors and related componen...

NVE Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Analyzes revenue across different business segments, highlighting which areas are driving growth and profitability, and where the company might need to adjust its strategy.
Chart InsightsNVE's product sales have shown volatility, with a recent uptick driven by a 21% increase in non-defense sales, despite a sharp decline in defense sales. Contract R&D revenue has plummeted, contributing to a 6% year-over-year revenue decline. The earnings call highlights new product launches in high-value markets like medical devices and EVs, suggesting a strategic pivot. However, the gross margin has narrowed due to a less profitable product mix, and the tax rate has risen, impacting net income. The company remains profitable, but these shifts indicate a challenging environment ahead.
Data provided by:The Fly

NVE Earnings Call Summary

Earnings Call Date:Jan 21, 2026
(Q3-2026)
|
% Change Since: |
Next Earnings Date:May 06, 2026
Earnings Call Sentiment Positive
The call conveyed a generally positive operational and financial picture: strong quarter-over-quarter revenue (+23%) and net income (+11%), meaningful cash generation, successful completion of a multi-year capacity expansion (equipment installed and to be placed into service), new product announcements, and an important two-year contractual extension with Abbott. Offsetting headwinds include gross margin compression (79% vs 84% prior year) driven by product mix and higher distributor sales, a higher effective tax rate in the quarter, reduced other income, and uneven year-to-date R&D revenue trends (9-month contract R&D down 8% and 9-month net income down 8%). Overall, the positive drivers (robust revenue growth, strong margins even after compression, cash flow, new capacity and product momentum, and customer wins) materially outweigh the identified challenges.
Positive Updates
Quarterly Revenue and Earnings Growth
Revenue for Q3 FY2026 increased 23% year-over-year. Net income rose 11% to $3.38 million ($0.70 per diluted share) from $3.05 million ($0.63). Product sales increased 16% and contract R&D revenue surged 335% in the quarter. Key profitability metrics remained strong: operating margin 60%, pretax margin 68%, and net margin 54%.
Negative Updates
Gross Margin Compression
Gross margin decreased to 79% of revenue in Q3 FY2026 from 84% in the prior year quarter (a 5 percentage-point decline). Management attributed the reduction to a less profitable product mix and increased distributor sales, which typically carry lower margins.
Read all updates
Q3-2026 Updates
Negative
Quarterly Revenue and Earnings Growth
Revenue for Q3 FY2026 increased 23% year-over-year. Net income rose 11% to $3.38 million ($0.70 per diluted share) from $3.05 million ($0.63). Product sales increased 16% and contract R&D revenue surged 335% in the quarter. Key profitability metrics remained strong: operating margin 60%, pretax margin 68%, and net margin 54%.
Read all positive updates
Company Guidance
The company guided that it expects to place its new wafer‑level chip‑scale equipment into service by March 31 (after $2.18M of fixed‑asset purchases in the first nine months, including $1.05M in the December quarter) and indicated operational tailwinds—distributor sales are picking up and defense revenues should return to a more normal flow; it also expects a full‑year fiscal‑2026 effective tax rate of about 16–17%, reflecting anticipated advanced manufacturing investment tax credits of $700k–$1.0M and accelerated R&D deductions that should reduce cash taxes by roughly $1.1M. For context the company reported Q3 revenue up 23% y/y (product sales +16%, contract R&D +335%), gross margin 79% (vs. 84% a year earlier), operating expenses down 12% (R&D −9%, SG&A −19%), net income up 11% to $3.38M ($0.70 diluted EPS) with operating/pretax/net margins of 60%/68%/54%, nine‑month revenue of $18.7M (+0.4%) and nine‑month net income of $10.3M (−8%, $2.12/sh), plus $12.2M cash flow from operations YTD, AR down $1.1M, inventories down $177k, prepaid/other up $323k and accrued liabilities down $366k.

NVE Financial Statement Overview

Summary
Strong overall fundamentals: exceptional profitability, a very conservative balance sheet with minimal leverage, and solid cash conversion. The main constraint is uneven growth, with revenue and cash flow cooling from prior peaks despite modest TTM improvement.
Income Statement
86
Very Positive
Balance Sheet
92
Very Positive
Cash Flow
84
Very Positive
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue25.95M25.87M29.80M38.25M26.99M21.37M
Gross Profit20.54M21.64M23.03M30.19M20.72M17.24M
EBITDA15.79M16.32M18.83M25.84M16.75M13.29M
Net Income14.16M15.06M17.12M22.69M14.51M11.69M
Balance Sheet
Total Assets59.96M64.28M66.78M69.26M67.47M72.50M
Cash, Cash Equivalents and Short-Term Investments20.57M21.73M22.20M17.18M31.29M18.11M
Total Debt1.71M921.23K355.15K518.71K602.14K731.73K
Total Liabilities1.67M2.01M1.21M2.18M2.90M1.61M
Stockholders Equity58.30M62.27M65.57M67.08M64.57M70.89M
Cash Flow
Free Cash Flow12.38M13.05M18.23M18.16M12.02M13.30M
Operating Cash Flow14.65M14.31M18.25M19.09M12.50M13.36M
Investing Cash Flow2.62M2.67M9.58M-8.53M7.02M8.42M
Financing Cash Flow-19.35M-19.23M-19.21M-19.34M-19.50M-19.43M

NVE Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price62.67
Price Trends
50DMA
67.58
Negative
100DMA
65.83
Positive
200DMA
66.19
Positive
Market Momentum
MACD
-0.17
Positive
RSI
46.10
Neutral
STOCH
21.21
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NVEC, the sentiment is Neutral. The current price of 62.67 is below the 20-day moving average (MA) of 68.31, below the 50-day MA of 67.58, and below the 200-day MA of 66.19, indicating a neutral trend. The MACD of -0.17 indicates Positive momentum. The RSI at 46.10 is Neutral, neither overbought nor oversold. The STOCH value of 21.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NVEC.

NVE Risk Analysis

NVE disclosed 13 risk factors in its most recent earnings report. NVE reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 3 New Risks
1.
We face the risk of credit losses Q1, 2024
2.
We could incur losses on our marketable securities. Q1, 2024
3.
Our business could be negatively impacted by cybersecurity events or information technology disruptions. Q1, 2024

NVE Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
$325.54M21.2023.47%6.28%-9.48%-14.28%
66
Neutral
$271.96M-11.321.74%-10.74%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
60
Neutral
$214.79M-357.39-0.80%-0.41%-134.49%
57
Neutral
$3.58B-10.41%-4.54%-119.39%
49
Neutral
$234.28M-41.41-9.33%307.44%14.77%
45
Neutral
$748.47M-1.501017.75%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NVEC
NVE
67.30
3.62
5.69%
AXTI
AXT
68.44
66.72
3879.07%
WOLF
Wolfspeed Inc
16.67
-11.93
-41.71%
MRAM
Everspin Technologies
9.29
4.14
80.39%
XPER
Xperi Inc
5.57
-2.62
-31.99%
ALMU
Aeluma, Inc.
12.98
6.73
107.68%

NVE Corporate Events

Dividends
NVE Corporation Declares Quarterly Cash Dividend for Shareholders
Positive
Jan 21, 2026
NVE Corporation declared a quarterly cash dividend of $1.00 per share of common stock, scheduled to be paid on February 27, 2026, to shareholders of record as of February 2, 2026. The announcement underscores the company’s continued commitme...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 23, 2026